Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01639417 · ClinicalTrials.gov registry record

Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients

A clinical trial of Breast Cancer and Pain, sponsored by Lynn Henry.

Completed
Registry status
39
Enrollment target
1
Study location

NCT01639417: Completed study of Breast Cancer and Pain, sponsored by Lynn Henry.

NCT01639417 is a study of Breast Cancer and Pain that has completed, run by Lynn Henry. The registered enrollment target is 39 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01639417, a study of Breast Cancer and Pain, has completed, sponsored by Lynn Henry.

COMPLETED
Registry status
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to better understand why some women with breast cancer develop chronic pain.

Primary Outcome

The primary objective of this pilot trial is to determine if there may be differences in mechanical pain sensitivity and functional MRI brain activation patterns in breast cancer survivors with chronic pain as compared to breast cancer patients without chronic pain, to patients with fibromyalgia, or to healthy controls.

Conditions Studied

Study Locations (1)

Michigan

  • University of Michigan Comprehensive Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2012-05
Est. Completion 2015-11
Lynn Henry

4 total trials

What the finished NCT01639417 record still lists

NCT01639417 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01639417 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01639417 about?

NCT01639417 is a clinical study titled "Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients". The purpose of this study is to better understand why some women with breast cancer develop chronic pain.

What is the current status of trial NCT01639417?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2012-05. Estimated completion is 2015-11.

What conditions does trial NCT01639417 study?

This clinical trial studies the following conditions: Breast Cancer, Pain.

Who is sponsoring clinical trial NCT01639417?

This trial is sponsored by Lynn Henry, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01639417 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01639417's enrollment target sits among peer trials

39 901st of 1224 higher than 316 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01639417, the US trial registry maintained by the National Library of Medicine. NCT01639417 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.